Glenmark Pharmaceuticals informs about media release

23 Mar 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 23rd March 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity’ which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1935.25 1.00 (0.05%)
21-Jan-2026 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.70
Dr. Reddys Lab 1164.30
Cipla 1371.20
Zydus Lifesciences 874.45
Lupin 2146.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×